RE: Toxicology report15 Mar 2022 18:46
Brilliant post sad. The data takes ages to analyse and that has to be done properly otherwise we look incompetent.
What are the views on all longterm holders into chk1 data found yesterday?
My take, the cake slice open to us just got better. More indications, now can see mono, duo, triple therapy options everywhere.